Qual o papel de Sglt 2 e agonistas GLP1 no tratamento de diabetes

Notas do episódio

Link Prescrire: https://english.prescrire.org/en/1256/3059/60686/0/PositionDetails.aspx Prescrire International • February 2021 • Volume 30 N° 223 Fonte Metaanálise: Link: https://www.bmj.com/content/372/bmj.m4573 Palmer SC, Tendal B, Mustafa RA, et al. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials. BMJ. 2021 Jan 13;372:m4573. doi: 10.1136/bmj.m4573. Contato: bemdespercebido@gmail.com